The DKFZ International PhD Program in Heidelberg (also known as the Helmholtz International Graduate School for Cancer Research) is the interdisciplinary structured graduate school for all PhD students working at the German Cancer Research Center (DKFZ). Our PhD students conduct research at the forefront of basic, computational, epidemiological and translational cancer research.
The long-term goal of the German Cancer Research Center is to unravel the causes and mechanisms of cancer development and, based on new insights, to develop novel tools for diagnosis, early detection, treatment and prevention.
In 2018, scientists at the DKFZ have published 1,864 research articles, many of them in high-ranking journals like Cell, Nature and Science.
- Cell Biology and Tumor Biology
- Functional and Structural Genomics
- Cancer Risk Factors and Prevention
- Tumor Immunology
- Imaging and Radiooncology
- Infection, Inflammation and Cancer
There is a lot of interaction at the DKFZ due to interdisciplinary collaborations and cross-topics:
- Computational Cancer Research and Data Science
- Medical Physics and Radiopharmacy
- Epidemiology and Biostatistics
- Cancer Epigenetics
- Infection and Immunology
PhD Funding
All PhD positions at the DKFZ are fully funded for (at least) three years. The salaries are competitive by national standards. There is no tuition fee.
Candidates awarded a PhD Program position through the biannual selection rounds are funded by a DKFZ PhD contract, which includes social security contributions (pension, health insurance etc). The amount of this contract is approximately equivalent to a TVöD contract with 65% working time, in the E13 level. Candidates may also receive offers of funding from a PhD supervisor directly.
All PhD students at the DKFZ are enrolled in the DKFZ International PhD Program, regardless of how they are funded.
For more information click "LINK TO ORIGINAL" below.